Virtu Financial LLC Macrogenics Inc Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$4.82 - $7.24 $111,419 - $167,359	23,116 New	23,116 $166,000
Q4 2020 Feb 24, 2021	SELL	$19.41 - $26.0 $194,759 - $260,884	-10,034 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$24.69 - $31.6 $247,739 - $317,074	10,034 New	10,034 $253,000
Q2 2019 Aug 13, 2019	SELL	$14.51 - $19.71 $165,805 - $225,226	-11,427 Closed	0 $0
Q1 2019 Apr 12, 2019	SELL	$11.11 - $25.6 $288,304 - $664,320	-25,950 Reduced 69.43%	11,427 $205,000
Q1 2018 May 14, 2018	BUY	$18.89 - $32.46 $706,051 - $1.21 Million	37,377 New	37,377 $940,000

132

55.4M

215K

238K

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.